MAP kinase/estrogen receptor cross-talk enhances estrogen-mediated signaling and tumor growth but does not confer tamoxifen resistance.
about
Phosphorylation of estrogen receptor alpha serine 167 is predictive of response to endocrine therapy and increases postrelapse survival in metastatic breast cancer.Hormone Use, Reproductive History, and Risk of Lung Cancer: The Women's Health Initiative StudiesPrior Adjuvant Tamoxifen Treatment in Breast Cancer Is Linked to Increased AIB1 and HER2 Expression in Metachronous Contralateral Breast CancerMicroRNA-134 targets KRAS to suppress breast cancer cell proliferation, migration and invasionEpidermal growth factor receptor signalling in human breast cancer cells operates parallel to estrogen receptor α signalling and results in tamoxifen insensitive proliferationEstrogen receptor β induces antiinflammatory and antitumorigenic networks in colon cancer cells.The Wilms' tumor suppressor WT1 induces estrogen-independent growth and anti-estrogen insensitivity in ER-positive breast cancer MCF7 cells.Estrogen regulation of anti-apoptotic Bcl-2 family member Mcl-1 expression in breast cancer cellsGenomic index of sensitivity to endocrine therapy for breast cancer.Deregulated miRNAs in hereditary breast cancer revealed a role for miR-30c in regulating KRAS oncogeneEffects of cadmium on estrogen receptor mediated signaling and estrogen induced DNA synthesis in T47D human breast cancer cells.Estrogen receptor α (ERα) mediates 17β-estradiol (E2)-activated expression of HBO1Lemur Tyrosine Kinase 2, a novel target in prostate cancer therapyPolymorphisms in the gene regions of the adaptor complex LAMTOR2/LAMTOR3 and their association with breast cancer riskLow concentrations of bisphenol A induce mouse spermatogonial cell proliferation by G protein-coupled receptor 30 and estrogen receptor-α.Phosphorylation of human estrogen receptor-beta at serine 105 inhibits breast cancer cell migration and invasion.Overexpression of estrogen receptor beta is a prognostic marker in non-small cell lung cancer: a meta-analysisThe Ras-MAPK signal transduction pathway, cancer and chromatin remodeling.Insulin-like growth factor 1 attenuates antiestrogen- and antiprogestin-induced apoptosis in ER+ breast cancer cells by MEK1 regulation of the BH3-only pro-apoptotic protein BimActivated estrogen receptor-mitogen-activated protein kinases cross talk confer acquired resistance to lapatinib.Estrogen-induced retinal endothelial cell proliferation: possible involvement of pigment epithelium-derived factor and phosphoinositide 3-kinase/mitogen-activated protein kinase pathways.V. Amygdalina: Folk Medicine, Analysis, and Potential Application for Cancer Treatment.Primate-specific oestrogen-responsive long non-coding RNAs regulate proliferation and viability of human breast cancer cells.Fatty acid synthase regulates estrogen receptor-α signaling in breast cancer cells.Downregulation of steroid hormone receptor expression and activation of cell signal transduction pathways induced by a chiral nonylphenol isomer in mouse sertoli TM4 cells.Co-planar 3,3',4,4',5-pentachlorinated biphenyl and non-co-planar 2,2',4,6,6'-pentachlorinated biphenyl differentially induce recruitment of oestrogen receptor alpha to aryl hydrocarbon receptor target genes.Estrogen receptor alpha and the activating protein-1 complex cooperate during insulin-like growth factor-I-induced transcriptional activation of the pS2/TFF1 gene.Upregulation of PKC-delta contributes to antiestrogen resistance in mammary tumor cells.A novel natural inhibitor of extracellular signal-regulated kinases and human breast cancer cell growth.Delayed and persistent ERK1/2 activation is required for 4-hydroxytamoxifen-induced cell death.Clinicopathological and prognostic significance of mitogen-activated protein kinases (MAPK) in breast cancers.Estrogen receptor signaling mediates leptin-induced growth of breast cancer cells via autophagy induction.Mango Fruit Extracts Differentially Affect Proliferation and Intracellular Calcium Signalling in MCF-7 Human Breast Cancer Cells
P2860
Q24813594-FA6C0631-F04A-4171-895F-F48CE358D184Q28392724-77200C76-2DFA-41BA-8693-4E7BF7202123Q28550645-051CC5C3-ADB1-47C7-92E2-F57911D385E2Q33599411-F61C3BFA-0CE9-43BD-8E8A-1267AF694BCBQ33612070-74129B54-8241-4D0E-AF01-0A0EB0213714Q33636941-E7A3946D-8FD0-48B3-B61D-511AA6F8E933Q33723383-4BCF047E-3F7E-4DA4-81B2-912D314DDA9BQ33817324-37C6E434-AA11-47E6-A6F0-59E55BA06E28Q34193932-B0D29612-B663-4820-86B0-93451431E320Q34305782-394FFBE7-E062-46B1-B462-E5032FB6C291Q34310691-D2EADA4D-C956-4E78-A8DF-14EBFA62B12AQ34341395-D44B8CA9-82C8-4130-9549-72FE832D3AFBQ34477815-031F5122-0B5F-4EDE-BB86-1F63762F167AQ34558708-7A58B6CE-67FB-4B00-B462-07858F6D0A2EQ35682920-2153F3CA-D686-4C93-8D19-C8BA584135B1Q35946502-68D89D02-B391-478D-BFDB-767E9FCE4E72Q35958787-C9D0E7DC-1530-444B-8309-97FF04164DA0Q36061535-44C3DDCA-D5E0-4CCF-ACED-14D0F585D903Q36245560-73E66F01-8296-4DC8-9619-AECD5C7A713EQ36247858-1F6F65A7-EAEF-4676-A7F7-776B24BFD92FQ36554012-488DA503-769B-4D2D-BF04-2EC6BA60AAA5Q36851311-B8B4CBE3-E0E9-495C-A9A6-4E86A06A8D23Q37548176-0E86BA17-74B1-4778-946D-1826DFC367F3Q37681205-B4333A0C-FC04-4595-A230-9D57ABF2FDC3Q38777513-696CDF20-9C2E-467A-AB5F-F5031F23DF5FQ40131034-24F72B36-EB1A-4913-82EA-ED21CE2131D4Q40167728-277D8D24-58FD-4F42-B7A1-4C2FC28CFFF5Q40453538-8516C372-E024-4689-AA08-65A875B5C013Q40597225-2D0650DE-287D-4C2F-82C5-B512309808D1Q40765604-76D97F95-4F5D-4BC1-B90D-524CF8FCF057Q41081937-A288F24B-00DC-4753-BAE7-382CA44FABA8Q49217184-E9CC3FCC-19A5-49AF-8D46-47460A1447ABQ59112358-712C3EC7-01C2-4F25-A0FB-079B187D6C58
P2860
MAP kinase/estrogen receptor cross-talk enhances estrogen-mediated signaling and tumor growth but does not confer tamoxifen resistance.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh-hant
name
MAP kinase/estrogen receptor c ...... t confer tamoxifen resistance.
@en
MAP kinase/estrogen receptor c ...... t confer tamoxifen resistance.
@nl
type
label
MAP kinase/estrogen receptor c ...... t confer tamoxifen resistance.
@en
MAP kinase/estrogen receptor c ...... t confer tamoxifen resistance.
@nl
prefLabel
MAP kinase/estrogen receptor c ...... t confer tamoxifen resistance.
@en
MAP kinase/estrogen receptor c ...... t confer tamoxifen resistance.
@nl
P2093
P2860
P356
P1433
P1476
MAP kinase/estrogen receptor c ...... ot confer tamoxifen resistance
@en
P2093
Fred Miller
Janice A Schwartz
Joseph S Krueger
Kaladhar B Reddy
Natasha Atanaskova
P2860
P2888
P304
P356
10.1038/SJ.ONC.1205506
P407
P577
2002-06-01T00:00:00Z